greeksoup/ stock research

Metlife (MET) Q1 FY2025 earnings: revenue $18.6 billion, up 15.6% on the year

Metlife Inc. (MET) reported revenue of $18.6 billion for Q1 FY2025, the quarter ended 31 March 2025, up 15.6% on the same quarter a year earlier. Net income was $945 million, up 9.0% on the year, and diluted earnings per share $1.28. The figures are the company's own, from the 10-Q it filed with the SEC on 1 May 2025.

Revenue
$18.6 billion
+15.6% on the year · -0.5% on the quarter
Q2 FY2023Q1 FY2025
Operating margin
7.6%
8.7% a year earlier
Q2 FY2023Q1 FY2025
Net income
$945 million
+9.0% on the year · -25.6% on the quarter
Q2 FY2023Q1 FY2025
Diluted EPS
$1.28
+16.4% on the year · -26.9% on the quarter
Q2 FY2023Q1 FY2025

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Revenue18,56918,66616,057-0.5%+15.6%
Operating income1,4151,4911,401-5.1%+1.0%
Operating margin7.6%8.0%8.7%
Pre-tax income1,3541,3811,045-2.0%+29.6%
Income tax404106170+281.1%+137.6%
Effective tax rate29.8%7.7%16.3%
Net income9451,271867-25.6%+9.0%
Net margin5.1%6.8%5.4%
Diluted EPS$1.28$1.75$1.10-26.9%+16.4%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Operating cash flow4,2624,6112,328-7.6%+83.1%
Cash from investing-3,322-5,364-2,627
Cash from financing220-519-261
Buybacks1,4114061,172+247.5%+20.4%
Dividends paid374378377-1.1%-0.8%
Dividend per share$0.55n/a$0.52+4.8%
Diluted shares, weighted687m711m728m-3.4%-5.7%
Shares outstanding at period end673m689m716m-2.3%-5.9%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Shareholders' equity27,49327,44528,535+0.2%-3.7%
Non-controlling interest262258261+1.6%+0.4%
Redeemable equityn/a0.0n/a
Short-term borrowings381465127-18.1%+200.0%
Debt14,69515,08615,972-2.6%-8.0%
Other liabilities645,485634,203632,681+1.8%+2.0%
Total liabilities and equity688,316677,457677,576+1.6%+1.6%
Goodwill9,0368,9019,037+1.5%-0.0%
Intangible assetsn/a710n/a
Investments5,5435,1564,884+7.5%+13.5%
Trading assets10,72510,67210,313+0.5%+4.0%
Cash and equivalents21,32620,06819,840+6.3%+7.5%
Other assets641,686631,950633,502+1.5%+1.3%
Total assets688,316677,457677,576+1.6%+1.6%

Questions

What was Metlife's revenue in Q1 FY2025?

Metlife (MET) reported revenue of $18.6 billion for Q1 FY2025, the quarter ended 31 March 2025, up 15.6% on the same quarter a year earlier.

How much did Metlife earn in Q1 FY2025?

Net income for Q1 FY2025 was $945 million, up 9.0% on the year, and diluted earnings per share $1.28.

When did Metlife report Q1 FY2025 results?

Metlife filed its 10-Q for the quarter ended 31 March 2025 with the SEC on 1 May 2025.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022 †Q2 FY2022 †Q3 FY2022 †Q4 FY2022Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue20,08915,40515,47422,27015,60815,38816,62315,86619,02816,05717,82318,44018,66618,56917,34017,36123,81419,07419,15420,522
Operating income1,3061,9359881,4022,0262574305349411,4011,6621,4421,4911,4151,3931,6501,6791,6311,6041,826
Operating margin7%13%6%6%13%2%3%3%5%9%9%8%8%8%8%10%7%9%8%9%
Pre-tax income1,3061,9359881,4151,7272574305349411,0451,2021,9941,3811,3549801,2101,1171,5071,0353,000
Tax rate7%15%7%18%22%67%5%7%35%16%21%33%8%30%25%25%27%23%25%20%
Net income1,2051,6349101,1621,57880.04024896078679461,3421,2719457298968091,1857362,397
Net margin6%11%6%5%10%1%2%3%3%5%5%7%7%5%4%5%3%6%4%12%
Diluted EPS$1.38$1.89$1.08$1.37$1.96$0.02$0.48$0.56$0.77$1.10$1.28$1.81$1.75$1.28$1.03$1.22$1.18$1.74$1.09$3.67
Operating cash flow5,3402,0404,4384,2782,5342,0263,0383,4755,1822,3283,4904,1694,6114,2622,1873,5677,0762,6872,2282,000
Buybacks1,1769401,1166745967806727928591,1728557744061,411510502460755722651
Dividends paid405397408400393389399392386377389383378374382378375372383379
Shares outstanding826m815m798m787m779m769m757m744m731m716m704m694m689m673m667m661m655m646m638m631m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2025, filed 1 May 2025: the filing.